Abstract
Deep venous thrombosis (DVT) is a common disorder with a significant mortality rate. Successful endovascular treatment of acute DVT is most likely to be achieved in patients with recently formed thrombus, (<10–14 days) with acute iliofemoral DVT. Endovascular treatment options include: Catheter-directed thrombolysis (CDT), pharmacomechanical catheter-directed thrombolysis (PCDT), percutaneous aspiration thrombectomy (PAT), vena cava filter protection, venous balloon dilatation and venous stent implantation. Current practice shows strong clinical tendency for the use of PCDT with or without other endovascular methods and an individualized approach for each DVT patient. PMT has not received general acceptance because of the associated risk of PE and damage to venous valves caused by thrombectomy devices. PAT is most commonly used as an adjunctive endovascular technique like balloon maceration to fragment thrombus, balloon angioplasty, stent implantation and vena cava filter placement. Interventional endovascular therapies for DVT have the potential to provide PE protection and prevention of PTS. Patient centered individualized approach for endovascular DVT treatment is recommended to optimize the ideal clinical result.
Acute stroke is the leading cause of death for people above the age of 60 and the fifth leading cause in people aged 15–59. Mortality during the first 30 days of ischemic stroke is 20 % and 30 % of survivors will remain permanently disabled. Acute stroke patients within the therapeutic window must receive IVrtPA unless there is a contraindication. In case of contraindication to IVrtPA or for patients out of the therapeutic window for thrombolytics, standart of care is the intraarterial treatment. Patients have to be transferred to a comprehensive stroke center with capacity of dedicated neurovascular imaging and interventional neuroradiology. Noncontrast head CT that is used to rule out hemorrhage is followed by imaging studies dedicated to show if there is reasonable penumbra to save. Intraarterial thrombolysis has the main advantage of extended therapy window, earlier and more efficient recanalization and less risk of hemorrhage due to lower doses of thrombolytics. Mechanical thrombectomy has several advantages over IV/IA fibrinolysis including faster recanalization and less risk of hemorrhage especially in large artery occlusions. ASA guidelines recommend choosing stent retrievers over other devices for mechanical thrombectomy. Better recanalization rates and less infarct volume after mechanical thrombectomy result in higher numbers of functionally independent patients compared with other treatments. Two landmark studies that were published recently, SWIFT PRIME and MR CLEAN, showed that IA treatment especially with the new stent retrievers lead to a significant increase in functional recovery and independence in daily life after an acute stroke.
Cerebral venous and sinus thrombosis (CVST) comprises nearly 0.5–1 % of all stroke cases. CVST causes different neurological deficits depending on the sinus/cortical vein involved. CVST may cause death and dependency in 13.4 % of patients. CT/CT venography and MR/MR venography can be effectively used to diagnose and to follow up CVT cases. Anticoagulation with heparin is the most widely accepted therapy to prevent the expansion of the thrombus. Patients deteriorating despite heparinization and patients presenting with very severe neurological deficits must receive endovascular treatment. Endovascular methods include intrasinus infusion of thrombolytics or heparin, balloon angioplasty, mechanical thrombectomy or a combination of different techniques. There is a higher rate or recanalization with endovascular methods compared to other medical therapies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fowkes FJ, Price JF, Fowkes FG (2003) Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg 25(1):1–5
Scarvelis D, Wells PS (2006) Diagnosis and treatment of deep vein thrombosis. CMAJ 175(9):1087–1092
Geerts W, Ray JG, Colwell CW, Bergqvist D, Pineo G, Lassen MR et al (2005) Prevention of venous thromboembolism. Chest 128(5):3775–3776
Vedantham S (2012) Interventional approaches to deep vein thrombosis. Am J Hematol 87(Suppl 1):S113–S118
Pernes JM, Auguste M, Kovarski S, Borie H, Renaudin JM, Coppe G (2012) Diagn Interv Imaging 93(10):725–733
Elsharawy M, Elzayat E (2002) Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. A randomized clinical trial. Eur J Vasc Endovasc Surg 24(3):209–214
Rogers LQ, Lutcher CL (1990) Streptokinase therapy for deep vein thrombosis: a comprehensive review of the English literature. Am J Med 88(4):389–395
Plate G, Eklof B, Norgren L, Ohlin P, Dahlstrom JA (1997) Venous thrombectomy for iliofemoral vein thrombosis 10 year results of a prospective randomized study. Eur J Vasc Endovasc Surg 14(5):367–374
Plate G, Einarsson E, Ohlin P, Jensen R, Qvarfordt P, Eklof B (1984) Thrombectomy with temporary arteriovenous fistula: the treatment of choice in acute iliofemoral venous thrombosis. J Vasc Surg 1(6):867–876
Vedantham S, Sista AK, Klein SJ, Nayak L, Razavi MK, Kalva SP, et al. Society of Interventional Radiology and Cardiovascular and Interventional Radiological Society of Europe Standards of Practice Committees (2014) Quality improvement guidelines for the treatment of lower-extremity deep vein thrombosis with use of endovascular thrombus removal. J Vasc Interv Radiol 25(9):1317–1325
Semba CP, Dake MD (1994) Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis. Radiology 191:487–494
Mewissen WM, Seabrook GR, Meissner MH, Cynamon J, Labropoulos N, Haughton SH (1999) Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a National Multicenter Registry. Radiology 211:39–49
Cakir V, Gulcu A, Akay E, Capar AE, Gencpinar T, Kucuk B et al (2014) Use of percutaneous aspiration thrombectomy vs. anticoagulation therapy to treat acute iliofemoral venous thrombosis: 1-year follow-up results of a randomized clinical trial. Cardiovasc Intervent Radiol 37:969–976
Sugimoto K, Hoffman LV, Razavi MK et al (2003) The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter directed thrombolysis of arterial and venous occlusions. J Vasc Surg 37:512–517
Vedantham S, Vesely TM, Sicard GA et al (2004) Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis. J Vasc Interv Radiol 15:565–574
Bush RL, Lin PH, Bates JT et al (2004) Pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis: safety and feasibility study. J Vasc Surg 40:965–970
Lin PH, Zhou W, Dardik A et al (2006) Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis. Am J Surg 192:782–788
Cynamon J, Stein EG, Dym J et al (2006) A new method for aggressive management of deep vein thrombosis: retrospective study of the power pulse technique. J Vasc Interv Radiol 17:1043–1049
O’Sullivan G, Lohan DG, Gough N et al (2007) Pharmacomechanical thrombectomy of acute deep vein thrombosis with the Trellis-8 isolated thrombolysis catheter. J Vasc Interv Radiol 18:715–724
Jaff MR, McMurtry MS, Archer SL et al (2011) Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 123:1788–1830
Turmel-Rodrigues L, Raynaud A, Louail B, Beyssen B, Sapoval M (2001) Manual catheter-directed aspiration and other thrombectomy techniques for declotting native fistulas for hemodialysis. J Vasc Interv Radiol 12(12):1365–1371
Oguzkurt L, Ozkan U, Gulcan O, Koca N, Gur S (2012) Endovascular treatment of acute and subacute iliofemoral deep venous thrombosis by using manual aspiration thrombectomy: long-term results of 139 patients in a single center. Diagn Interv Radiol 18(4):410–416
Mackay J, Mensah G, Mendis S, Greenlund K (2004) Atlas of heart disease and stroke. World Health Organization, Geneva
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M et al. on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2015) Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation 27;131(4):e29–322. doi:10.1161/CIR.0000000000000152
Rosamond W, Flegal K, Furie K et al (2008) Heart disease and stroke statistics: 2008 update—a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117:e25–e146
Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM et al. American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Peripheral Vascular Disease, Council on Clinical Cardiology (2013) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44(3):870–947
Christou I, Burgin WS, Alexandrov AV, Grotta JC (2001) Arterial status after intravenous TPA therapy for ischaemic stroke: a need for further interventions. Int Angiol 20:208–213
Furlan A, Higashida R, Wechsler L et al (1999) Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282(21):2003–2011
Lisboa RC, Jovanovic BD, Alberts MJ (2002) Analysis of the safety and efficacy of intra-arterial thrombolytic therapy in ischemic stroke. Stroke 33(12):2866–2871
IMS Study Investigators (2004) Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 35:904–911
Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, et al. Interventional Management of Stroke (IMS) III Investigators (2013) Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 368(10):893–903. doi:10.1056/NEJMoa1214300
Wolpert SM, Bruckmann H, Greenlee R et al (1993) Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator: the rtPA Acute Stroke Study Group. AJNR Am J Neuroradiol 14:3–13
Nogueira RG, Schwamm LH, Hirsch JA (2009) Endovascular approaches to acute stroke, Part 1: Drugs, devices, and data. AJNR Am J Neuroradiol 30:649–661
IMS II Trial Investigators (2007) The Interventional Management of Stroke (IMS) II study. Stroke 38:2127–2135
Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC et al (2000) Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology 55:1649–1655
Nogueira RG, Smith WS (2009) Safety and efficacy of endovascular thrombectomy in patients with abnormal hemostasis: pooled analysis of the MERCI and Multi MERCI trials. Stroke 40:516–522
Higashida RT, Furlan AJ, Roberts H et al (2003) Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 34:e109–e137
Kallmes DF (2012) TICI: if you are not confused, then you are not paying attention. AJNR Am J Neuroradiol 33:975–976
Smith WS, Sung G, Starkman S et al (2005) Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 36:1432–1438
Smith WS, Sung G, Saver J et al (2008) Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 39:1205–1212
Bose A, Henkes H, Alfke K et al (2008) The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 29:1409–1413
Penumbra Pivotal Stroke Trial Investigators (2009) The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 40(8):2761–2768. doi:10.1161/STROKEAHA.108.544957
Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG et al. SWIFT Trialists (2012) Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 380:1241–1249
Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA, et al. TREVO 2 Trialists (2012) Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomized trial. Lancet 380:1231–1240
Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM et al. SWIFT PRIME Investigators (2015) Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tpa with IV tpa alone in acute ischemic stroke. Int J Stroke 10(3):439–448. doi: 10.1111/ijs.12459
Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM et al. SWIFT PRIME Investigators (2015) Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 372(24):2285–95. doi:10.1056/NEJMoa1415061
Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ et al. MR CLEAN Investigators (2015) A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372(1):11–20. doi:10.1056/NEJMoa1411587
Mehta B, Leslie-Mazwi TM, Chandra RV et al (2013) Assessing variability in neurointerventional practice patterns for acute ischemic stroke. J Neurointerv Surg 5(Suppl 1):i52–i57
Stam J (2005) Thrombosis of the cerebral veins and sinuses. N Engl J Med 352:1791–1798
Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM (1998) High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 338(25):1793–1797
Cantú C, Barinagarrementeria F (1993) Cerebral venous thrombosis associated with pregnancy and puerperium. Review of 67 cases. Stroke 24(12):1880–1884
Rahmanian R, Wan Fook Cheung V, Chadha NK (2015) Non-fatal extensive cerebral venous thrombosis as a complication of adenotonsillectomy. Int J Pediatr Otorhinolaryngol 79(2):254–258. doi:10.1016/j.ijporl.2014.11.016
Emir M, Ozisik K, Cagli K, Bakuy V, Ozisik P, Sener E (2004) Dural sinus thrombosis after cardiopulmonary bypass. Perfusion 19(2):133–135
Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F (2004) Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 35(3):664–670
Girot M, Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F et al. ISCVT Investigators (2007) Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhage. Stroke 38(2):337–342. Epub 2007 Jan 4
Linn J, Pfefferkorn T, Ivanicova K, Müller-Schunk S, Hartz S, Wiesmann M et al (2009) Noncontrast CT in deep cerebral venous thrombosis and sinus thrombosis: comparison of its diagnostic value for both entities. AJNR Am J Neuroradiol 30(4):728–735. doi:10.3174/ajnr.A1451
Bonneville F (2014) Imaging of cerebral venous thrombosis. Diagn Interv Imaging 95(12):1145–1150. doi:10.1016/j.diii.2014.10.006
Bracken J, Barnacle A, Ditchfield M (2013) Potential pitfalls in imaging of paediatric cerebral sinovenous thrombosis. Pediatr Radiol 43(2):219–231. doi:10.1007/s00247-012-2402-6
Linn J, Brückmann H (2010) Cerebral venous and dural sinus thrombosis: state-of-the-art imaging. Clin Neuroradiol 20(1):25–37. doi:10.1007/s00062-010-9035-7
Einhaupl K, Bousser MG, de Bruijn SF, Ferro JM, Martinelli I, Masuhr F et al (2006) EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol 13:553–559
Bousser MG, Ferro JM (2007) Cerebral venous thrombosis: an update. Lancet Neurol 6:162–170
Coutinho JM, Ferro JM, Canhaõ P, Barinagarrementeria F, Bousser MG, Stam J, for the ISCVT investigators (2010) Unfractionated or low–molecular weight heparin for the treatment of cerebral venous thrombosis. Stroke 41:2575–2580
Masuhr F, Mehraein S (2004) Cerebral venous and sinus thrombosis: patients with a fatal outcome during intravenous dose-adjusted heparin treatment. Neurocrit Care 1(3):355–361
Rahman M, Velat GJ, Hoh BL, Mocco J (2009) Direct thrombolysis for cerebral venous sinus thrombosis. Neurosurg Focus 27(5):E7. doi:10.3171/2009.7.FOCUS09146
Rael JR, Orrison WW Jr, Baldwin N, Sell J (1997) Direct thrombolysis of superior sagittal sinus thrombosis with coexisting intracranial hemorrhage. AJNR Am J Neuroradiol 18:1238–1242
Philips MF, Bagley LJ, Sinson GP, Raps EC, Galetta SL, Zager EL et al (1999) Endovascular thrombolysis for symptomatic cerebral venous thrombosis. J Neurosurg 90:65–71
Chaloupka JC, Mangla S, Huddle DC (1999) Use of mechanical thrombolysis via microballoon percutaneous transluminal angioplasty for the treatment of acute dural sinus thrombosis: case presentation and technical report. Neurosurgery 45:650–657
Chow K, Gobin YP, Saver J, Kidwell C, Dong P, Vinuela F (2000) Endovascular treatment of dural sinus thrombosis with rheolytic thrombectomy and intra-arterial thrombolysis. Stroke 31:1420–1425
Curtin KR, Shaibani A, Resnick SA, Russell EJ, Simuni T (2004) Rheolytic catheter thrombectomy, balloon angioplasty, and direct recombinant tissue plasminogen activator thrombolysis of dural sinus thrombosis with preexisting hemorrhagic infarctions. AJNR Am J Neuroradiol 25:1807–1811
Newman CB, Pakbaz R, Nguyen A, Kerber C (2009) Endovascular treatment of extensive cerebral sinus thrombosis. J Neurosurg 110:442–445
Frey JL, Muro GJ, McDougall CG, Dean BL, Jahnke HK (1999) Cerebral venous thrombosis: combined intrathrombus rtPA and intravenous heparin. Stroke 30:489–494
Wasay M, Bakshi R, Kojan S, Bobustuc G, Dubey N, Unwin DH (2001) Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin anticoagulation for superior sagittal sinus thrombosis. Stroke 32:2310–2317
Soleau SW, Schmidt R, Stevens S, Osborn A, Macdonald J (2003) Extensive experience with dural sinus thrombosis. Neurosurgery 52:534–544
Stam J, Majoie CB, van Delden OM, van Lienden KP, Reekers JA (2008) Endovascular thrombectomy and thrombolysis for severe cerebral sinus thrombosis: a prospective study. Stroke 39:1487–1490
La Barge DV 3rd, Bishop FS, Stevens EA, Eskandari R, Schmidt RH, Skalabrin EJ et al (2009) Intrasinus catheter-directed heparin infusion in the treatment of dural venous sinus thrombosis. AJNR Am J Neuroradiol 30(9):1672–1678. doi:10.3174/ajnr.A1677
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Goktay, A.Y., Senturk, C. (2016). Endovascular Treatment of Thrombosis and Embolism. In: Islam, M. (eds) Thrombosis and Embolism: from Research to Clinical Practice. Advances in Experimental Medicine and Biology(), vol 906. Springer, Cham. https://doi.org/10.1007/5584_2016_116
Download citation
DOI: https://doi.org/10.1007/5584_2016_116
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-22107-6
Online ISBN: 978-3-319-22108-3
eBook Packages: MedicineMedicine (R0)